Source - LSE Regulatory
RNS Number : 2903L
Creo Medical Group PLC
09 September 2021
 

Creo Medical Group plc

("Creo" or the "Company")

 

Director/PDMR Shareholding

 

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that Charles Spicer, Non-Executive Chairman, purchased 9,657 Ordinary Shares through the Open Offer at the Offer Price of 182.5 pence per Ordinary Share via his Self-Invested Personal Pension ('SIPP').  Following this purchase and Admission of the New Ordinary Shares on 7 September 2021 Charles Spicer holds 127,976 Ordinary Shares in the Company via his SIPP, representing approximately 0.07% of the Company's issued share capital.  

 

Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular dated 16 August 2021.

 

Creo Medical Group plc

investors.creomedical.com

Richard Rees (CFO)

+44 (0)1291 606 005

 

 

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys / Camilla Hume (NOMAD)

 

Michael Johnson / Russell Kerr (Sales)

 

 

 

Walbrook PR Ltd

Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com

Paul McManus / Lianne Cawthorne 

Mob: +44 (0)7980 541 893 / +44 (0)7515 909 238 

 

 

The information below, set out in accordance with the requirements of the MAR, provides further detail. 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Charles Spicer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Creo Medical Group plc

b)

 

LEI

 

 

213800H188ZDCWWXFA21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of £0.001 each

 

GB00BZ1BLL44

 

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

182.5p

 

9,657

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

N/A

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

7 September 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFIAIIAIIL
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.